Movement Disorders+ Summit 2022

Download All
This comprehensive program features presentations and slide decks from the world’s leading experts in neurology. Gain knowledge in current diagnostic and therapeutic approaches for patients with a range of movement and neurologic disorders. Topics include Alzheimer’s disease, epilepsy, essential tremor and other tremor disorders, migraine, hyperkinetic movement disorders, myasthenia gravis, Parkinson’s disease, and tardive dyskinesia. Learners can access webcasts and downloadable slides for future reference and use.
Jacqueline French, MD
Nada Hindiyeh, MD
Stuart Isaacson, MD
person default
Jonathan Katz, MD
person default
Daniel Kremens, MD, JD
Rajesh Pahwa, MD
Marwan Sabbagh, MD, FAAN
Marta San Luciano, MD, MS, FAAN
Victor W. Sung, MD
Gil Wolfe, MD, FAAN

Distinguishing Tardive Dyskinesia from Other Drug-Induced Movement Disorders

The presentation will focus on tardive dyskinesia, clinical pearls to distinguish it from other drug-induced movement disorders, and how assessment of the impact of tardive dyskinesia can aid treatment decisions with first-line VMAT2 inhibitor therapy.

Stuart Isaacson, MD Released: September 27, 2022

Diagnosis and Management of Parkinson’s Disease Dementia

The presentation will discuss the cardinal features of Parkinson’s disease dementia, how it differs from dementia with Lewy bodies and Parkinson’s disease, diagnostic strategies, and pharmacologic and nonpharmacologic strategies.

Marwan Sabbagh, MD, FAAN Released: September 27, 2022

Planning Ahead: Development of a Seizure Action Plan With Rescue Medications

Slides from the epilepsy presentation at the 2022 Movement Disorders+ Summit.

Jacqueline French, MD Released: September 22, 2022

Targeting CGRP for the Treatment of Migraine

Slides from the migraine presentation at the 2022 Movement Disorders+ Summit.

Nada Hindiyeh, MD Released: September 26, 2022

Management of Neuropsychiatric Features in Alzheimer’s Disease Dementia

This presentation will discuss how to recognize the psychiatric symptoms associated with dementia, the on-label and off-label medications and strategies used in Alzheimer’s disease psychosis, and dementia-related psychosis, and new and emerging treatments for treating neuropsychiatric symptoms in Alzheimer’s disease dementia.

Marwan Sabbagh, MD, FAAN Released: September 19, 2022

A Changing Treatment Paradigm of Myasthenia Gravis: A Focus on Novel Targeted Treatments

This presentation will educate healthcare providers on the historical treatment of myasthenia gravis, how the newer agents change the treatment paradigm, and demonstrate how to treat various subtypes of myasthenia gravis through patient case examples.

person default Jonathan Katz, MD Gil Wolfe, MD, FAAN Released: September 23, 2022

Managing Advanced Parkinson’s Disease: Adjunctive Therapies

The presentation will focus on patients with Parkinson’s disease, motor fluctuation, and dyskinesia and the use of adjunctive therapies to levodopa to improve their OFF time and improve their good time during the day.

Rajesh Pahwa, MD Released: September 26, 2022

Hyperkinetic Movement Disorders: Importance of Differential Diagnosis When Symptoms Overlap

Slides from the hyperkinetic movement disorders presentation at the 2022 Movement Disorders+ Summit.

Victor W. Sung, MD Released: September 23, 2022

Beyond Pharmacotherapy: Advancements in Surgical Therapies for Parkinson’s Disease

The presentation will focus on the indications and appropriateness for surgical therapies (deep brain stimulation, carbidopa/levodopa intestinal gel therapy, and high frequency MR-guided focused ultrasound) in Parkinson’s disease.

Marta San Luciano, MD, MS, FAAN Released: September 26, 2022

Updates in Diagnosis and Treatment of Essential Tremor

Slides from the essential tremor presentation at the 2022 Movement Disorders+ Summit.

person default Daniel Kremens, MD, JD Released: September 27, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings